Fasting
Fasting is an intervention with 77 clinical trials. Currently 18 active trials ongoing. Historical success rate of 91.7%.
Success Metrics
Based on 44 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.0%
44 of 50 finished
12.0%
6 ended early
18
trials recruiting
77
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intermittent Fasting on Body Fat and Quality of Life
The Meta-SHIFT Study: How Metabolic Shift Shapes Human Immunometabolism - a Fasting Trial
Thermogenic Silencer Regulatory Factors in Humans
Dance and Energy Expenditure Among Adults With Parkinson's
A Study of Time-Restricted Eating in Childhood Cancer Survivors
Clinical Trials (77)
Intermittent Fasting on Body Fat and Quality of Life
The Meta-SHIFT Study: How Metabolic Shift Shapes Human Immunometabolism - a Fasting Trial
Thermogenic Silencer Regulatory Factors in Humans
Dance and Energy Expenditure Among Adults With Parkinson's
A Study of Time-Restricted Eating in Childhood Cancer Survivors
Continuous Enteral Feeding Until Tracheostomy and Aspiration Risk
Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy
Effect of Fasting on Patient Outcomes After Wide-Awake, Local Anesthesia-only, No Tourniquet (WALANT) Procedures
Feasibility of Intermittent Fasting During Chemotherapy
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
Breath Analysis & Malnutrition
Breaking Fasts Ahead of Cardiac Caths
The Effects of 24-hour Fasting or Carbohydrate Restriction on Postprandial Metabolic Responses
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Caused by Fasting
Effect of Macronutrients on Post-Exercise Glycemic Response in Males With Type 2 Diabetes
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 77